Transduction of Liver Metastases After Intravenous Injection of Ad5/35 or Ad35 Vectors With and Without Factor X-Binding Protein Pretreatment

Citations Over TimeTop 13% of 2009 papers

Abstract

Inefficient tumor transduction with targeted adenoviral vectors is largely due to unspecific virus sequestration by blood components, including coagulation factor X, and Kupffer cell scavenging. In this study, we show that preinjection of snake venom factor X-binding protein (X-bp) reduces hepatocyte transduction and increases the circulation time in blood of an intravenously injected, fiber-chimeric Ad5/35 vector. X-bp pretreatment resulted in improved Ad5/35 transduction of liver metastases and increased the antitumor efficacy of an Ad5/35-based oncolytic adenovirus. Furthermore, we demonstrate that a vector based on adenoviral serotype 35, which is less sequestered by factor X, is efficient in tumor targeting. This gives a rationale for using Ad35-based vectors in virotherapy of cancer.

Related Papers

• → Delivery of oncolytic adenovirus into the nucleus of tumorigenic cells by tumor microparticles for virotherapy(2016)99 cited
• → Adenovirus and Immunotherapy: Advancing Cancer Treatment by Combination(2020)48 cited
• → Adenovirus Receptor Expression in Cancer and Its Multifaceted Role in Oncolytic Adenovirus Therapy(2020)46 cited
• → Photoactivatable oncolytic adenovirus for optogenetic cancer therapy(2020)19 cited
• → Tropism and transduction of oncolytic adenovirus vectors in prostate cancer therapy(2021)4 cited